Catalyst Wire Dossier Catalyst Wire Dossier

Diphtheria-Tetanus-Acellular Pertussis Vaccine

diphtheria-tetanus-acellular pertussis vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Diphtheria-Tetanus-Acellular Pertussis Vaccine, covering 2010-12-17 to 2010-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine [Phase 3]

See pricing